General Information of This Metabolic Reaction (MR) (ID:
MR001505) |
Formula |
Reactant |
Levomilnacipran |
Product |
N-desethyl LVM |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME Info
|
Cytochrome P450 2D6 (CYP2D6)
|
DME Info
|
Cytochrome P450 2J2 (CYP2J2)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Desmethylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
LABEL:EVOMILNACIPRAN capsule, extended release
|
2 |
The role of levomilnacipran in the management of major depressive disorder: a comprehensive review. Curr Neuropharmacol. 2016;14(2):191-9.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.